CellWell record HH-435409
Melatonin-selenium nanoformulation: a promising therapeutic strategy against Ehrlich ascites carcinoma
Hanaa M Morad; A F Abdel-Aziz; Mai M Madkour
2026
In plain language
In mice with Ehrlich ascites carcinoma, melatonin-selenium nanoparticles inhibited tumor growth, lowered IL-6 and induced caspase-3-linked apoptosis, with greater effect than melatonin, selenium, or selenium nanoparticles alone.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-435409
Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.